1 recruiting. 1 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 1 | Recruiting 1 |
Follow Neuromuscular Blockade Reversal Agent: new trials by email Literature Review of Neuromuscular Blockade Reversal Agent trials Research Report on Neuromuscular Blockade Reversal Agent
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Sugammadex-Induced Clenching During Neuromuscular Blockade Reversal Sugammadex 1 mg/kg Group, Sugammadex 2 mg/kg Group, Sugammadex 4 mg/kg Group - Neuromuscular Blockade Reversal Agent, Perioperative Complications | Not applicable | Recruiting | Wonkwang University Hospital | 240 | 2025-07-01 | 2026-07-07 |
Trismus (1)
Nervous System Diseases (1) · Neurologic Manifestations (1) · Neuromuscular Manifestations (1) · Pathological Conditions, Signs and Symptoms (1) · Signs and Symptoms (1) · Spasm (1)
Epinephrine (1) · Population Groups (1) · Pyridostigmine Bromide (1) · S 1 (combination) (1) · Sugammadex (1)
Wonkwang University Hospital (1)
South Korea (1)